The importance of cervical cancer screening in the U.S.Why is cervical screening so important in the U.S. and globally? And how has the pandemic affected that screening? 

Today’s episode features Chris Beddard, VP of US Marketing at BD. She joins the podcast today to discuss a product she and her team have been working on to improve the lives of women. Chris is passionate about bringing awareness about health options to women around the world. 

Listen to the episode to hear what Chris has to say about why the test she’s been working on is special, what kinds of challenges a team faces when developing these tests, and why cervical cancer screening is so important. 

Some of the highlights of today’s episode include:

• What BD is doing and how Chris is working with it
• How to go about choosing specific treatments to target
• What makes the current test special
• Cervical screening focus on women in Africa
• Challenges in developing tests
• Why cervical cancer screening matters so much
• The ongoing impact of the pandemic on testing
• Advice for medical health professionals in the process of long-term development

Memorable quotes from Chris Beddard:

“Extended genotyping provides different information, information that’s critical to a clinician to basically manage a woman’s risk for developing cervical cancer or precancer.”

“In order to get all three testing paradigms approved through the FDA, there was an extensive clinical trials that did take place, again spanning many years.”

“HPV is the most common sexually transmitted infection in the United States.”

“We’re seeing women returning to testing; we’re seeing –again –our view of healthcare changing based on the pandemic.”

Links:

Chris Beddard

BD

Etienne Nichols LinkedIn

etienne.nichols@greenlight.guru

MedTech Excellence Community

Greenlight Guru Academy

Greenlight Guru